1. Scrip

Israel's Medtech Market Evolution: Seeking The Next Big Thing

 
• By Catherine Longworth

Medtronic’s multi-billion-dollar acquisition of Mazor Robotics in 2018 marked a record-breaking milestone for Israel’s life sciences industry as the largest amount ever paid for an Israeli company in the medical sector, beating Mitsubishi Tanabe Pharma’s $1.1 billion acquisition of Neuroderm in 2017. In Vivo investigates how aMoon II, a new VC fund, aims to produce the industry’s next big giant.

Israel’s Medtech Market Evolution feat image
What's next for Israel's medtech sector? • Source: Shutterstock

Following a $1.65 billion mammoth acquisition by Medtronic PLC, Mazor Robotics Ltd. now tops the list as Israel’s most richly valued company in the medical sector. The blockbuster deal, which should help Medtronic carve out a competitive position in spine surgery robotics, was welcomed in Israel as proof of the country’s growing leadership in health care innovation.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from AI

More from Digital Technologies